Heat shock protein B6 potently increases non‑small cell lung cancer growth

Chen,Shaomu; Huang,Haitao; Yao,Jie; Pan,Liangbin; Ma,Haitao

doi:10.3892/mmr.2014.2240

Heat shock protein B6 potently increases non‑small cell lung cancer growth

Authors:
- Shaomu Chen
- Haitao Huang
- Jie Yao
- Liangbin Pan
- Haitao Ma
View Affiliations

Affiliations: Department of Cardiothoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
Published online on: May 15, 2014 https://doi.org/10.3892/mmr.2014.2240
Pages: 677-682

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to address the effects of heat shock protein B6 (HspB6) on tumor growth and metastasis in BALB/c mice. Lewis lung carcinoma (LLC) cells were subcutaneously injected into BALB/c mice followed by intraperitoneal injection of recombinant HspB6 (HspB6 groups) or phosphate‑buffered saline (control groups). Tumor growth and metastasis were assessed by size measurement and weighing of tumors and cervical lymph nodes, respectively. Chemokine expression in tumor masses was quantified quantitative polymerase chain reaction and western blotting. Tumor cell apoptosis was detected by flow cytometric analysis. The proliferation and migration of LLC cells, stimulated with HspB6, were detected using Cell Counting Kit 8 and wound scratch assays in vitro. Tumors grafted into the BALB/c mice and intraperitoneally injected with HspB6 were significantly bigger in size than those grafted into the control mice. From 7 days following the injection, the weight of cervical lymph nodes in HspB6 groups was higher than that in the control mice. We also revealed that the apoptotic cell number in tumor masses in the HspB6 groups was lower than that of the control mice. CD31 expression of vascular endothelial cells was higher in tumors grafted in HspB6 groups than those grafted in the control mice. Concomitantly, the tumor tissue mRNA and protein expression enhancement of vascular endothelial growth factor, basic fibroblast growth factor and intercellular adhesion molecule 1 were greater in HspB6 mice than in the control mice. HspB6 also inhibited cell apoptosis and enhanced the migration and proliferation of LLCs in vitro. In conclusion, HspB6 exhibited tumor promotion through increasing tumor angiogenesis, tumor metastasis and inhibiting tumor cell apoptosis.

View Figures

View References

1	Stanley K and Stjernswärd J: Lung cancer - a worldwide health problem. Chest. 96:1S–5S. 1989. View Article : Google Scholar : PubMed/NCBI
2	Larsen JE and Minna JD: Molecular biology of lung cancer: clinical implications. Clin Chest Med. 32:703–740. 2011. View Article : Google Scholar : PubMed/NCBI
3	Nakagawa K, Sasaki Y, Kato S, et al: 22-Oxa-1alpha, 25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis. 26:1044–1054. 2005. View Article : Google Scholar : PubMed/NCBI
4	Thatcher N: New perspectives in lung cancer. 4. Haematopoietic growth factors and lung cancer treatment. Thorax. 47:119–126. 1992. View Article : Google Scholar : PubMed/NCBI
5	Weynants P, Marchandise FX and Sibille Y: Pulmonary perspective: immunology in diagnosis and treatment of lung cancer. Eur Respir J. 10:1703–1719. 1997. View Article : Google Scholar : PubMed/NCBI
6	Latchman DS: Heat shock proteins and cardiac protection. Cardiovasc Res. 51:637–646. 2001. View Article : Google Scholar : PubMed/NCBI
7	Willis MS and Patterson C: Hold me tight: Role of the heat shock protein family of chaperones in cardiac disease. Circulation. 122:1740–1751. 2010. View Article : Google Scholar : PubMed/NCBI
8	Fan GC, Chu G and Kranias EG: Hsp20 and its cardioprotection. Trends Cardiovasc Med. 15:138–141. 2005. View Article : Google Scholar : PubMed/NCBI
9	Fan GC and Kranias EG: Small heat shock protein 20 (Hsp20) in cardiac hypertrophy and failure. J Mol Cell Cardiol. 51:574–577. 2011. View Article : Google Scholar : PubMed/NCBI
10	Edwards HV, Cameron RT and Baillie GS: The emerging role of HSP20 as a multifunctional protective agent. Cell Signal. 23:1447–1454. 2011. View Article : Google Scholar : PubMed/NCBI
11	Wang X, Zhao T, Huang W, et al: Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells. 27:3021–3031. 2009.PubMed/NCBI
12	Schmitt E, Gehrmann M, Brunet M, et al: Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol. 81:15–27. 2007. View Article : Google Scholar : PubMed/NCBI
13	Calderwood SK, Mambula SS, Gray PJ Jr, et al: Extracellular heat shock proteins in cell signaling. FEBS Lett. 581:3689–3694. 2007. View Article : Google Scholar : PubMed/NCBI
14	Zhan R, Leng X, Liu X, et al: Heat shock protein 70 is secreted from endothelial cells by a non-classical pathway involving exosomes. Biochem Biophys Res Commun. 387:229–233. 2009. View Article : Google Scholar : PubMed/NCBI
15	Song X and Luo Y: The regulatory mechanism of Hsp90alpha secretion from endothelial cells and its role in angiogenesis during wound healing. Biochem Biophys Res Commun. 398:111–117. 2010. View Article : Google Scholar : PubMed/NCBI
16	Hecker JG and McGarvey M: Heat shock proteins as biomarkers for the rapid detection of brain and spinal cord ischemia: a review and comparison to other methods of detection in thoracic aneurysm repair. Cell Stress Chaperones. 16:119–131. 2011. View Article : Google Scholar : PubMed/NCBI
17	Niwa M, Kozawa O, Matsuno H, et al: Small molecular weight heat shock-related protein, HSP20, exhibits an anti-platelet activity by inhibiting receptor-mediated calcium influx. Life Sci. 66:PL7–PL12. 2000.PubMed/NCBI
18	Zhang X, Wang X, Zhu H, et al: Hsp20 functions as a novel cardiokine in promoting angiogenesis via activation of VEGFR2. PLoS One. 7:e327652012. View Article : Google Scholar : PubMed/NCBI
19	Noda T, Kumada T, Takai S, et al: Expression levels of heat shock protein 20 decrease in parallel with tumor progression in patients with hepatocellular carcinoma. Oncol Rep. 17:1309–1314. 2007.PubMed/NCBI
20	Myung JK, Afjehi-Sadat L, Felizardo-Cabatic M, et al: Expressional patterns of chaperones in ten human tumor cell lines. Proteome Sci. 2:82004. View Article : Google Scholar : PubMed/NCBI
21	Srivastava S, Lundqvist A and Childs RW: Natural killer cell immunotherapy for cancer: a new hope. Cytotherapy. 10:775–783. 2008. View Article : Google Scholar : PubMed/NCBI
22	Levy EM, Roberti MP and Mordoh J: Natural killer cells in human cancer: from biological functions to clinical applications. J Biomed Biotechnol. 2011:6761982011.PubMed/NCBI
23	Hwang YJ, Kim J, Park DS and Hwang KA: Study on the Immunomodulation Effect of Isodon japonicus Extract via Splenocyte Function and NK Anti-Tumor Activity. Int J Mol Sci. 13:4880–4888. 2012. View Article : Google Scholar : PubMed/NCBI
24	Kozawa O, Matsuno H, Niwa M, et al: HSP20, low-molecular-weight heat shock-related protein, acts extracellularly as a regulator of platelet functions: a novel defense mechanism. Life Sci. 72:113–124. 2002. View Article : Google Scholar : PubMed/NCBI
25	Ichinose Y, Yano T, Asoh H, et al: Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage. J Thorac Cardiovasc Surg. 110:601–605. 1995. View Article : Google Scholar : PubMed/NCBI
26	van Velzen E, Snijder RJ, Brutel de la Rivière A, et al: Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastases. Chest. 110:1469–1473. 1996.PubMed/NCBI
27	Mountain CF and Dresler CM: Regional lymph node classification for lung cancer staging. Chest. 111:1718–1723. 1997. View Article : Google Scholar : PubMed/NCBI
28	Costantini C and Cassatella MA: The defensive alliance between neutrophils and NK cells as a novel arm of innate immunity. J Leukoc Biol. 89:221–233. 2011. View Article : Google Scholar : PubMed/NCBI
29	Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
30	Senger DR, Galli SJ, Dvorak AM, et al: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:983–985. 1983. View Article : Google Scholar